Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 70.75M
47.81x6.38x-0.76x5.3x22.4x30.77x2.59% 320B
24.6x2.07x-18.42x3.37x12.01x19.63x1.6% 72.44B
11.8x12.49x0.07x5.99x9.22x10.13x - 9.42B
17.31x1.49x0.86x2.2x7.57x9.05x2.58% 8.65B
22.99x6.12x2.31x6.56x18.53x19.38x-.--% 4.41B
38.98x - 0.25x7.33x20.96x33.95x - 4.52B
39.09x2.33x-1.27x2.21x26.99x40.6x0.79% 3.43B
110.89x - -0.68x - - - -.--% 2.79B
17.04x0.75x-0.62x1.33x23.74x40.64x4.15% 1.05B
51.84x - -0.1x - - - - 1.03B
-7.54x12.42x0.48x207.14x-6.71x-5.24x-.--% 980M
Average 34.07x 5.50x -1.63x 26.82x 14.97x 22.10x 1.46% 35.73B
Weighted average by Cap. 42.28x 5.63x -3.65x 5.39x 19.95x 27.91x 2.35%
Specialty & Advanced Pharmaceuticals